BofA/Merrill Lynch Upgrades Achillion Pharmaceuticals (ACHN) to Buy
Tweet Send to a FriendGet Alerts ACHN Hot Sheet
Price: $8.13 +1.50%
Rating Summary:
14 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Rating Summary:
14 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 22
Trade ACHN Now!
BofA/Merrill Lynch upgraded Achillion Pharmaceuticals (NASDAQ: ACHN) from Underperform to Buy.
For an analyst ratings summary and ratings history on Achillion Pharmaceuticals click here. For more ratings news on Achillion Pharmaceuticals click here.
Shares of Achillion Pharmaceuticals closed at $8.10 yesterday, with a 52 week range of $3.81-$12.95.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For an analyst ratings summary and ratings history on Achillion Pharmaceuticals click here. For more ratings news on Achillion Pharmaceuticals click here.
Shares of Achillion Pharmaceuticals closed at $8.10 yesterday, with a 52 week range of $3.81-$12.95.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- UPDATE: BofA/Merrill Lynch Upgrades Adobe (ADBE) to Buy
- Argus Upgrades Toll Bros. (TOL) to Buy
- Goldman Sachs Upgrades Mizuho Financial Group Inc. (MFG) to Buy
Create E-mail Alert Related Categories
Hot Upgrades, UpgradesRelated Entities
Merrill Lynch, Bank of America
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
